SCHEMBL2808284

SCHEMBL2808284

Nc1cc(C(=O)OC2CCCCC2)cc(C(=O)OC2CCCCC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 4/20 0.51
STS P08842 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HTT P42858 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MMP9 P14780 2/20 0.43
MMP12 P39900 2/20 0.43
MMP1 P03956 1/20 0.43
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
MMP2 P08253 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
NR1I2 O75469 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27794285 0.98 SERPINE1 (0.53) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL6577408 0.91 SERPINE1 (0.60) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL343297 0.89 SERPINE1 (0.62) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL14828376 0.84 SERPINE1 (0.54) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL2611728 0.84 SERPINE1 (0.53) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL6857436 0.84 SERPINE1 (0.58) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL6851327 0.84 SERPINE1 (0.58) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL6857427 0.84 SERPINE1 (0.58) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL7054328 0.84 SERPINE1 (0.53) SERPINE1STSSMN1; SMN2LMNAMAPT
SCHEMBL9120449 0.83 STS (0.50) STSSMN1; SMN2LMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240908-A1 ACETYLENE COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
EP-2202221-A1 ACETYLENE COMPOUND Fujifilm Corporation (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240908-A1 ACETYLENE COMPOUND NAT1, KATNA1, KAT2B SERPINE1 2154/4885STS 3614/4885SMN1; SMN2 2933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.